GL1X · GenesisL1 explorer

MolNFT v1 · #126650 · protein

Synthesis and biological evaluation of new triazolo and imidazolopyridine rorgt inverse agonists

5M96 · Nuclear receptor ror-gamma: “Synthesis and biological evaluation of new triazolo and imidazolopyridine rorgt inverse agonists”. X-ray diffraction, 1 ligand (Q6Y), 10 pockets (best druggability 0.82). MolNFT v1 #126650 on GenesisL1…

PDB
5M96
Type
protein
Length
448 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma
UniProt
P51449
Ligands
Q6Y
Pockets
10 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 74% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gammaprotein22574% helix, 4% strandP51449
BNuclear receptor ror-gammaprotein22374% helix, 4% strandP51449

Ligands and binding sites

  • Q6Y · ~{N}-[8-[[(3~{S})-4-cyclopentylcarbonyl-3-methyl-piperazin-1-yl]methyl]-7-methyl-imidazo[1,2-a]pyridin-6-yl]-2-methyl-pyrimidine-5-carboxamide · ligand · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13390.820.9139Q6Y
29870.810.8272Q6Y
33410.810.9041Q6Y
42470.540.7721empty
51310.500.8018empty

Interfaces

1 interface between chains.

  • A–B · 885 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 5M96 · Synthesis and biological evaluation of new triazolo and imidazolopyridine RORgt inverse… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.